RxDoctor Payments Data

Francois Soto Palou, MD

Urology · San Juan, PRNPI 1598162182

Payments from drug & device makers

What this record shows

This record is dominated by grants: $25,000 of the $26,332 with a category attached, or 94.9%. Boston Scientific accounts for 96.2% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2021 at $25,107 and has fallen 99.2% since, to $210 in 2025.

$26,332in general payments, 2019–2025

Across 14 payments — averaging $1880.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$25K
  • Teleflex LLC$368
  • Olympus Latin America, Inc.$125
  • Verity Pharmaceuticals Inc.$120
  • Ambu Inc.$118
  • E.r. Squibb & Sons, L.L.C.$100
  • plus $163 from 3 others

What the payments were for

  • Grants$25,00095%
  • Food & beverage$1,3325%

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Boston Scientific4$25,339
Teleflex LLC3$368
Olympus Latin America, Inc.1$125
Verity Pharmaceuticals Inc.1$120
Ambu Inc.1$118
E.r. Squibb & Sons, L.L.C.1$100
Johnson & Johnson1$90
Olympus Corporation Of The Americas1$61
PBG Puerto Rico LLC1$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$26,332 in reported general payments places this provider in the 85th percentile of 122 urology providers in Puerto Rico.

See all urology providers in Puerto Rico

Medicare billing

Part B allowed, 2024
$37,044
Medicare patients
95
Services billed
266

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MyrbetriqMirabegron19$11,470
Tolterodine Tartrate ErTolterodine Tartrate104$9,455
Tamsulosin Hcl175$2,405
Potassium Citrate ErPotassium Citrate15$1,802
Estradiol12$876
Methenamine Hippurate15$616
Sildenafil Citrate20$462
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav43$434
Oxybutynin Chloride ErOxybutynin Chloride16$421
Bicalutamide18$395
Levofloxacin31$317
Meloxicam47$146
Gentamicin Sulfate14$131
Cephalexin25$114

Paid to pharmacies, not to this prescriber.

Other urology in San Juan

See the full list for Puerto Rico

Where these figures come from

Is this you, or does something look wrong? →